Sekmek, S. Et Al. 2024. Effect of HER2/CEP17 ratio on survival in metastatic HER2-positive gastric cancer, multicenter study. Clinical and Translational Oncology , vol.26, no.8 , 1878-1885.

Sekmek, S., Karahan, I., Ucar, G., Ceylan, F., Bayram, D., Seven, I., ... BÖLEK, H.(2024). Effect of HER2/CEP17 ratio on survival in metastatic HER2-positive gastric cancer, multicenter study. Clinical and Translational Oncology , vol.26, no.8, 1878-1885.

Sekmek, Serhat Et Al. "Effect of HER2/CEP17 ratio on survival in metastatic HER2-positive gastric cancer, multicenter study," Clinical and Translational Oncology , vol.26, no.8, 1878-1885, 2024

Sekmek, Serhat Et Al. "Effect of HER2/CEP17 ratio on survival in metastatic HER2-positive gastric cancer, multicenter study." Clinical and Translational Oncology , vol.26, no.8, pp.1878-1885, 2024

Sekmek, S. Et Al. (2024) . "Effect of HER2/CEP17 ratio on survival in metastatic HER2-positive gastric cancer, multicenter study." Clinical and Translational Oncology , vol.26, no.8, pp.1878-1885.

@article{article, author={Serhat Sekmek Et Al. }, title={Effect of HER2/CEP17 ratio on survival in metastatic HER2-positive gastric cancer, multicenter study}, journal={Clinical and Translational Oncology}, year=2024, pages={1878-1885} }